A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

Conditions:   Chronic Plaque Psoriasis;   Moderate to Severe Chronic Plaque Psoriasis Interventions:   Other: Placebo;   Drug: Bimekizumab Sponsor:   UCB Biopharma SRL Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials